VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
This Quarter Return
+7.59%
1 Year Return
-12.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.27B
AUM Growth
+$1.27B
(-5.5%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-13.98%
Top 10 Holdings %
Top 10 Hldgs %
50.64%
Holding
85
New
23
Increased
22
Reduced
17
Closed
16
Top Buys
| 1 |
Insmed
INSM
|
$62.1M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$49.5M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$33.8M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$28.1M |
| 5 |
Structure Therapeutics
GPCR
|
$25.9M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$74.7M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$66.8M |
| 3 |
Globus Medical
GMED
|
$61.6M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$58.3M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$49.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Prime Medicine
PRME
$556M
| $4.14M | 0.31% |
1,070,000
+620,000
| +138% | +$2.4M |
|
52
Ventyx Biosciences
VTYX
$175M
| $3.76M | 0.29% |
1,725,000
+410,000
| +31% | +$894K |
|
53
Zevra Therapeutics
ZVRA
$509M
| $3.64M | 0.28% |
+525,000
| New | +$3.64M |
|
54
Ardelyx
ARDX
$1.54B
| $3.45M | 0.26% |
+500,000
| New | +$3.45M |
|
55
PTC Therapeutics
PTCT
$3.92B
| $2.97M | 0.23% |
80,000
-10,000
| -11% | -$371K |
|
56
Penumbra
PEN
$10.6B
| $2.91M | 0.22% |
+15,000
| New | +$2.91M |
|
57
Voyager Therapeutics
VYGR
$186M
| $2.87M | 0.22% |
490,000
-110,000
| -18% | -$644K |
|
58
MacroGenics
MGNX
$110M
| $2.73M | 0.21% |
830,000
+30,000
| +4% | +$98.7K |
|
|
VERV
59
DELISTED
Verve Therapeutics
VERV
| $2.54M | 0.19% |
525,000
+25,000
| +5% | +$121K |
|
|
ITCI
60
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.2M | 0.17% |
+30,000
| New | +$2.2M |
|
61
Establishment Labs
ESTA
$1.2B
| $1.73M | 0.13% |
+40,000
| New | +$1.73M |
|
62
Relmada Therapeutics
RLMD
$47.1M
| $1.59M | 0.12% |
490,000
-710,000
| -59% | -$2.3M |
|
|
ACHL
63
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $1.53M | 0.12% |
1,500,000
| – | – |
|
|
OKUR
64
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $1.36M | 0.1% |
799,400
+254,400
| +47% | +$432K |
|
|
CMRX
65
DELISTED
Chimerix, Inc.
CMRX
| $1.3M | 0.1% |
1,400,000
| – | – |
|
66
Atara Biotherapeutics
ATRA
$86.7M
| $1.01M | 0.08% |
124,677
+12,677
| +11% | +$103K |
|
67
Tenax Therapeutics
TENX
$27.3M
| $288K | 0.02% |
+83,333
| New | +$288K |
|
68
ALX Oncology
ALXO
$55.2M
| – | – |
-3,600,000
| Closed | -$21.7M |
|
69
Apellis Pharmaceuticals
APLS
$3.48B
| – | – |
-335,000
| Closed | -$12.9M |
|
|
AVDL
70
Avadel Pharmaceuticals
AVDL
$1.45B
| – | – |
0
| – | – |
|
71
Axsome Therapeutics
AXSM
$6.05B
| – | – |
-300,000
| Closed | -$24.2M |
|
72
Biohaven
BHVN
$1.68B
| – | – |
0
| – | – |
|
73
BioNTech
BNTX
$24.2B
| – | – |
-100,000
| Closed | -$8.04M |
|
74
Denali Therapeutics
DNLI
$2.26B
| – | – |
-500,000
| Closed | -$11.6M |
|
75
Dyne Therapeutics
DYN
$1.92B
| – | – |
-225,000
| Closed | -$7.94M |
|